Ovid Therapeutics Inc. (OVID)
Market Closed
16 Oct, 08:00 PM
$
2. 15
-0.11
-4.8673%
$
419.89M Market Cap
- P/E Ratio
- Div Yield
1.33M Volume
-0.58 Eps
$ 2.26
Previous Close 
Want to track OVID and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ovid Therapeutics Inc. (OVID) Statistics
Valuation metrics
Market Cap 419.89M
Enterprise value 421.28M
Trailing P/E (ttm) -4.48
Forward P/E -5.84
PEG ratio 0.13
Price/Sales (ttm) 265.25
Price/Book (mrq) 0.76
Enterprise Value/Revenue 266.13
Enterprise Value/EBITDA -11.82
Overview
Shares outstanding 130.18M
Float 113.96M
Shares short 8.53M
% Held by insiders 0.08%
% Held by institutions 0.37%
Average volume (10 days) 1.36M
Average volume (90 days) 1.58M
Price summary
52-Week low 1.18
52-Week high 3.1
Beta 0.18
50-Day moving average 2.55
200-Day moving average 2.57
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -21.79%
Operating margin -36.87%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.24%
Income Statement
Revenue (ttm) 7.25M
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) 8.45%
Gross profit (ttm) 7.25M
EBITDA -42.17M
Net income to common (ttm) -17.14M
Diluted EPS (ttm) -0.47
Quarterly earnings growth (yoy) 8.45%
Balance Sheet
Total cash (mrq) 69.64M
Total cash per share (mrq) 1.59
Total debt (mrq) 13.42M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 12.39%
Book value per share (mrq) 2.85
Cash Flow
Cash flow statement -38.33M
Levered free cash flow (LFCF) -25.64M
2026 © Marketlog. All Rights Reserved.
